Patents by Inventor Dayong Li

Dayong Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200216465
    Abstract: The present invention relates to certain diaryl macrocyclic compounds, pharmaceutical compositions containing them, and methods of using them, including methods for treating cancer, pain, neurological diseases, autoimmune diseases, and inflammation.
    Type: Application
    Filed: February 21, 2020
    Publication date: July 9, 2020
    Inventors: Jingrong Jean Cui, Yishan Li, Evan W. Rogers, Dayong Zhai
  • Patent number: 10689400
    Abstract: The present disclosure relates to certain macrocyclic kinase inhibitors, pharmaceutical compositions containing the same, and methods of using the same to treat disease.
    Type: Grant
    Filed: July 27, 2017
    Date of Patent: June 23, 2020
    Assignee: Turning Point Therapeutics, Inc.
    Inventors: Jingrong Jean Cui, Yishan Li, Evan W. Rogers, Dayong Zhai, Jane Ung
  • Patent number: 10643469
    Abstract: The present invention provides a traffic intersection driving assistance method and system, wherein the method comprises: acquiring driving information about vehicles within a current intersection area by way of vehicle interconnection; obtaining vehicle flows in various driving directions according to the driving information; determining whether a difference in between vehicle flows in various driving directions exceeds a pre-set threshold, and if so, changing a driving direction of a variable lane; and sending information about the distribution of driving directions of current lanes to the vehicles within the current intersection area. The object of the present invention is to avoid traffic congestion by adjusting a variable lane in time.
    Type: Grant
    Filed: May 20, 2016
    Date of Patent: May 5, 2020
    Assignees: ZHEJIANG GEELY AUTOMOBILE RESEARCH INSTITUTE CO., LTD, ZHEJIANG GEELY HOLDING GROUP CO., LTD.
    Inventors: Xuefeng Li, Ke Huo, Bo Li, Dayong Zhou, Weiguo Liu, Chengming Wu, Qingfeng Feng
  • Patent number: 10618912
    Abstract: The present invention relates to certain diaryl macrocyclic compounds, pharmaceutical compositions containing them, and methods of using them, including methods for treating cancer, pain, neurological diseases, autoimmune diseases, and inflammation.
    Type: Grant
    Filed: November 29, 2018
    Date of Patent: April 14, 2020
    Assignee: Turning Point Therapeutics, Inc.
    Inventors: Jingrong Jean Cui, Yishan Li, Evan W. Rogers, Dayong Zhai
  • Publication number: 20200075640
    Abstract: An array substrate, manufacturing method thereof, and display device are disclosed. The array substrate includes signal lines; IC connection lines; the IC connection lines include at least two IC connection line groups, the at least two IC connection line groups comprise a first IC connection line group and a second IC connection line group, the array substrate further includes a lead, an orthographic projection of the lead on a straight line in a second direction is overlapped or connected with an orthographic projection of a first IC connection line in the first IC connection line group which is closest to the second IC connection line group on the straight line in a second direction and an orthographic projection of the second IC connection line in the second IC connection line group which is closest to the first IC connection line group on the straight line in a second direction respectively.
    Type: Application
    Filed: May 9, 2019
    Publication date: March 5, 2020
    Applicants: Hefei Xinsheng Optoelectronics Technology Co., Ltd., BOE Technology Group Co., Ltd.
    Inventors: Xingxing Song, Zhenfei Cai, Dayong Yu, Kun Yu, Zhongzhen Li, Wenjie Wang
  • Publication number: 20190382728
    Abstract: Disclosed are angiogenesis stimulatory mesenchymal-like cells derived from menstrual blood, originating from endometrium and expressing increased levels of the protein CD39 as compared to other cells found from the menstrual blood. In one embodiment, menstrual blood mononuclear cells are plated on adherent culture and allowed to grow in a manner permitting expansion of mesenchymal-like cells. Said expanded cells are selected for expression of CD39 and utilized for stimulation of angiogenesis. In other embodiments, menstrual blood derived adherent cells are cultured with platelet derived factors in order to augment angiogenic ability, directly, or through upregulation of CD39 expression.
    Type: Application
    Filed: February 22, 2019
    Publication date: December 19, 2019
    Applicant: Beijing Regenesis Biotechnology Co., Ltd
    Inventors: Feng Lin, Fei Li, Dayong Zhang, Thomas Emanuel Ichim
  • Patent number: 10484468
    Abstract: Disclosed are a method and a device for downloading a file. The method includes: when receiving a download request of a file, acquiring attribute information about the file, and learning information about the length of the file according to the attribute information about the file; when the length of the file goes beyond a preset value, segmenting the download request into at least two fragments of download requests; sending the at least two fragments of download requests to at least two data nodes to request to download corresponding fragments, and obtaining the at least two fragments; and according to the at least two fragments obtained by download, obtaining the file. By segmenting the download request into a plurality of fragments of requests, the present invention achieves the parallel download of the plurality of fragments of requests, thereby greatly improving the download efficiency of a file.
    Type: Grant
    Filed: February 18, 2015
    Date of Patent: November 19, 2019
    Assignee: TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED
    Inventors: Haijun Wu, Rui Li, Yongqiang Zou, Shengyu Dong, Taifu Que, Lei Wang, Shaopeng Yang, Shuxin Zhang, Dayong Zhao, Chang Liu, Xiaodong Chen, Yinfeng Zhang
  • Publication number: 20190284209
    Abstract: The present disclosure relates to certain chiral diaryl macrocyclic derivatives, pharmaceutical compositions containing them, and methods of using them to treat cancer, pain, neurological diseases, autoimmune diseases, and inflammation.
    Type: Application
    Filed: May 29, 2019
    Publication date: September 19, 2019
    Inventors: Jingrong J. CUI, Yishan LI, Evan W. ROGERS, Dayong ZHAI, Wei DENG, Jane UNG
  • Patent number: 10316044
    Abstract: The present disclosure relates to certain chiral diaryl macrocyclic derivatives of the formula I pharmaceutical compositions containing them, and methods of using them to treat cancer, pain, neurological diseases, autoimmune diseases, and inflammation.
    Type: Grant
    Filed: June 30, 2016
    Date of Patent: June 11, 2019
    Assignee: TP Therapeutics, Inc.
    Inventors: Jingrong J. Cui, Yishan Li, Evan W. Rogers, Dayong Zhai, Wei Deng, Jane Ung
  • Publication number: 20190169207
    Abstract: The present invention relates to certain diaryl inacrocyclic compounds, pharmaceutical compositions containing them, and methods of using them, including methods for treating cancer, pain, neurological diseases, autoimmune diseases, and inflammation.
    Type: Application
    Filed: November 29, 2018
    Publication date: June 6, 2019
    Inventors: Jingrong Jean Cui, Yishan Li, Evan W. Rogers, Dayong Zhai
  • Publication number: 20190169208
    Abstract: The present disclosure relates to certain macrocyclic kinase inhibitors, pharmaceutical compositions containing the same, and methods of using the same to treat disease.
    Type: Application
    Filed: July 27, 2017
    Publication date: June 6, 2019
    Inventors: Jingrong Jean CUI, Yishan LI, Evan W. ROGERS, Dayong ZHAI, Jane UNG
  • Patent number: 9944942
    Abstract: The present invention provides transgenic plants having increased tolerance to abiotic stress comprising a recombinant nucleic acid molecule, said recombinant nucleic acid molecule comprising a nucleotide sequence encoding miR319 operatively associated with a promoter, a nucleotide sequence that is antisense to a portion of consecutive nucleotides of a nucleotide sequence encoding PCF5, and/or a nucleotide sequence that encodes a portion of consecutive nucleotides of a nucleotide sequence encoding PCF5, which when expressed produces an antisense nucleotide sequence, wherein expression of the nucleotide sequence confers increased tolerance to abiotic stress. Also provided are methods and compositions for making said transgenic plants.
    Type: Grant
    Filed: November 8, 2012
    Date of Patent: April 17, 2018
    Assignee: CLEMSON UNIVERSITY
    Inventors: Hong Luo, Dayong Li, Man Zhou, Qian Hu
  • Patent number: 9771286
    Abstract: The present invention relates to an apparatus for biological sewage treatment, including a concentrated mixed liquor driving device that uses a gas to drive a concentrated mixed liquor to flow. The present invention further relates to a method for biological sewage treatment, including a step of using a gas to drive a concentrated mixed liquor to flow. The gas can be an aeration gas, especially an oxygen-containing aeration gas after aeration treatment. The apparatus and method of the present invention can sufficiently utilize the energy and oxygen of the aeration gas, so that the energy consumption and maintenance cost of whole apparatus are reduced, biological sewage treatment effects are improved, and sludge floating is prevented. In addition, the apparatus of present invention has advantages of high performance, energy saving, high reliability, and good movability.
    Type: Grant
    Filed: July 5, 2013
    Date of Patent: September 26, 2017
    Inventors: Jinmin Li, Liankui Zhou, Dayong Li
  • Patent number: 9507132
    Abstract: An object of the present invention is to provide a low-cost, miniature, wide-angle high-zoom-ratio zoom lens that has high imaging performance, and an imaging apparatus equipped with the zoom lens. To achieve the object, a zoom lens including a first lens group having positive refracting power, a second lens group having negative refracting power and a third lens group having positive refracting power in order from an object side in which a lens group P having positive refracting power is arranged closer to an image plane side than the third lens group.
    Type: Grant
    Filed: December 10, 2014
    Date of Patent: November 29, 2016
    Assignee: Tamron Co., Ltd.
    Inventors: Yoshito Iwasawa, Dayong Li
  • Publication number: 20160202457
    Abstract: A wide-angle zoom lens includes: a first lens group having a negative refractive power, a second lens group having positive refractive power, a third lens group having a negative refractive power and a fourth lens group having a positive refractive power in that order from an object side. The second lens group is configured with a front group, a stop and a rear group having a positive refractive power in that order from the object side. Magnification change is performed by changing distances among the lens groups.
    Type: Application
    Filed: January 7, 2016
    Publication date: July 14, 2016
    Inventor: Dayong Li
  • Patent number: 9229204
    Abstract: A zoom lens includes sequentially from an object side, a first lens section G11 having a negative refractive power and a second lens section G12 having a positive refractive power. The first lens section G11 includes sequentially from the object side, a negative lens L111, a negative lens L112, and a positive lens L113. Both surface of the negative lens L112 are aspheric. The second lens section G12 includes sequentially from the object side, a front group G12F having a positive refractive power and a rear group G12R having a positive refractive power. Both surfaces of a negative lens L126 included in the rear group G12R are aspheric. The zoom lens can maintain high imaging performance while achieving size reductions and wide angle views by satisfying given conditions.
    Type: Grant
    Filed: July 9, 2012
    Date of Patent: January 5, 2016
    Assignee: TAMRON CO., LTD.
    Inventor: Dayong Li
  • Patent number: 9176308
    Abstract: A zoom lens includes sequentially from an object side, a first lens group having a positive refractive power, a second lens group having a negative refractive power, a third lens group having a positive refractive power, a fourth lens group having a negative refractive power, a fifth lens group having a positive refractive power, and a sixth lens group having a negative refractive power. The zoom lens varies the interval between the lens groups to perform zooming; shifts the second lens group in a direction substantially orthogonal to the optical axis to correct image blur occurring with optical system vibrations; and satisfies given conditions, enabling a compact size and a high zoom ratio to be achieved while improving imaging performance.
    Type: Grant
    Filed: February 4, 2014
    Date of Patent: November 3, 2015
    Assignees: TAMRON CO., LTD., SONY CORPORATION
    Inventors: Dayong Li, Daisuke Kuroda, Takuya Kato
  • Patent number: 9169143
    Abstract: A pretreatment method is provided, which comprises the following steps: (1) wastewater feed is introduced into a first end of a first aeration basin, and is mixed with a first concentrated mixed liquor to obtain a first mixed liquor; (2) the first mixed liquor is aerated in the aeration stage of the first aeration basin to obtain a second mixed liquor at a second end of the first aeration basin; (3) the second mixed liquor is introduced into a first sedimentation basin to obtain a supernatant and the first concentrated mixed liquor; (4) the supernatant is discharged and at least a part of the first concentrated mixed liquor is returned to the first end of the first aeration basin. At the same time, a sewage treatment method using the wastewater pretreatment method is provided. The pretreatment method can be used steadily for a long time without discharging sludge.
    Type: Grant
    Filed: December 1, 2010
    Date of Patent: October 27, 2015
    Inventors: Jinmin Li, Liankui Zhou, Dayong Li
  • Patent number: 9150441
    Abstract: A sewage treatment apparatus comprises a first stage equipment for treating sewage feed to obtain a first effluent and a second stage equipment for treating the first effluent to obtain a second effluent. The second stage equipment comprises a mixer (VI) for mixing the first effluent and a flocculation agent to obtain the first effluent containing the flocculation agent and a flocculation-clarification equipment (VII) comprises a first flocculation reaction chamber (A), into which the first effluent containing the flocculation agent is entered and subjected to flocculation reaction to form a mixture of water and dreg; a first separation chamber (C), into which the mixture of water and dreg from the first flocculation reaction chamber (A) is entered and separated to obtain a first part of the second effluent and a first dreg; and a second separation chamber (D), into which part of the first dreg is entered and separated to obtain a second part of the second effluent and a second dreg.
    Type: Grant
    Filed: December 1, 2010
    Date of Patent: October 6, 2015
    Inventors: Jinmin Li, Liankui Zhou, Dayong Li
  • Publication number: 20150166381
    Abstract: The present invention relates to an apparatus for biological sewage treatment, including a concentrated mixed liquor driving device that uses a gas to drive a concentrated mixed liquor to flow. The present invention further relates to a method for biological sewage treatment, including a step of using a gas to drive a concentrated mixed liquor to flow. The gas can be an aeration gas, especially an oxygen-containing aeration gas after aeration treatment. The apparatus and method of the present invention can sufficiently utilize the energy and oxygen of the aeration gas, so that the energy consumption and maintenance cost of whole apparatus are reduced, biological sewage treatment effects are improved, and sludge floating is prevented. In addition, the apparatus of present invention has advantages of high performance, energy saving, high reliability, and good movability.
    Type: Application
    Filed: July 5, 2013
    Publication date: June 18, 2015
    Inventors: Jinmin LI, Liankui ZHOU, Dayong LI